From: Substance use in sexual minority youth: prevalence in an urban cohort
Substance no-use vs. use | SMY reference: HET | SMY-males reference: HET-males | SMY-females reference: HET-females | |||||||
---|---|---|---|---|---|---|---|---|---|---|
 | Age | OR | 95% CI | p value | OR | 95% CI | p value | OR | 95% CI | p value |
Tobacco | 17 | 0.99 | 0.56–1.75 | 0.98 | 0.72 | 0.30–1.72 | 0.46 | 1.21 | 0.54–2.72 | 0.65 |
20 | 1.28 | 0.82–1.99 | 0.28 | 0.57 | 0.29–1.13 | 0.11 | 2.06 | 1.09–3.89 | 0.03 | |
Alcohol | 17 | 1.91 | 0.68–5.38 | 0.22 | 3.42 | 0.38–30.92 | 0.27 | 1.45 | 0.44–4.81 | 0.54 |
20 | 1.63 | 0.65–4.1 | 0.30 | 1.45 | 0.3–6.99 | 0.65 | 2.06 | 0.61–6.92 | 0.24 | |
Cannabis | 17 | 1.34 | 0.77–2.33 | 0.29 | 0.58 | 0.22–1.49 | 0.26 | 2.14 | 1.04–4.38 | 0.04 |
20 | 1.48 | 0.96–2.27 | 0.07 | 0.84 | 0.41–1.70 | 0.62 | 2.24 | 1.28–3.91 | 0.004 | |
Ecstasy/MDMA | 17 | 2.93 a | 1.22–7.07 | 0.02 | 0.81 a | 0.09–7.81 | 0.86 | 4.29 a | 1.40–13.15 | 0.01 |
20 | 2.70 | 1.65–4.44 |  < 0.001 | 2.30 | 1.06–5.00 | 0.04 | 3.93 | 1.88–8.2 |  < 0.001 | |
Stimulants | 17 | 2.46 a | 0.99–6.12 | 0.05 | 3.07 a | 0.66–14.16 | 0.15 | 2.64 a | 0.75–9.29 | 0.13 |
20 | 1.74 | 1.05–2.88 | 0.03 | 1.18 | 0.54–2.59 | 0.67 | 3.45 | 1.58–7.53 | 0.002 | |
Hallucinogens | 17 | 5.11 a | 1.98–13.22 |  < 0.001 | 4.22 a | 0.87–20.47 | 0.07 | 5.59 a | 1.39–22.49 | 0.02 |
20 | 2.86 | 1.63–5.00 |  < 0.001 | 2.43 | 1.10–5.37 | 0.03 | 6.65 a | 2.34–18.88 |  < 0.001 | |
Opioids | 17 | n/a | n/a | n/a | ||||||
20 | 0.78 | 0.46–1.3 | 0.33 | 0.79 | 0.34–1.83 | 0.59 | 0.83 | 0.42–1.65 | 0.59 | |
Benzodiazepines | 17 | n/a | n/a | n/a | ||||||
20 | 1.14 | 0.54–2.39 | 0.73 | 0.96 | 0.25–3.71 | 0.95 | 1.91 | 0.71–5.16 | 0.20 |